Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2003 6
2004 5
2005 6
2006 2
2007 2
2008 3
2009 3
2010 5
2011 7
2012 10
2013 13
2014 14
2015 16
2016 21
2017 21
2018 24
2019 17
2020 22
2021 29
2022 25
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Among authors: hesselink da. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.
Mycophenolate revisited.
van Gelder T, Hesselink DA. van Gelder T, et al. Among authors: hesselink da. Transpl Int. 2015 May;28(5):508-15. doi: 10.1111/tri.12554. Transpl Int. 2015. PMID: 25758949 Free article. Review.
Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19.
Lemaitre F, Budde K, Van Gelder T, Bergan S, Lawson R, Noceti O, Venkataramanan R, Elens L, Moes DJAR, Hesselink DA, Pawinski T, Johnson-Davis KL, De Winter BCM, Pattanaik S, Brunet M, Masuda S, Langman LJ. Lemaitre F, et al. Among authors: hesselink da. Ther Drug Monit. 2023 Apr 1;45(2):191-199. doi: 10.1097/FTD.0000000000001014. Ther Drug Monit. 2023. PMID: 35944126 Free article.
Costimulation Blockade in Kidney Transplant Recipients.
van der Zwan M, Hesselink DA, van den Hoogen MWF, Baan CC. van der Zwan M, et al. Among authors: hesselink da. Drugs. 2020 Jan;80(1):33-46. doi: 10.1007/s40265-019-01226-6. Drugs. 2020. PMID: 31749062 Free PMC article. Review.
Exploring the neuroregenerative potential of tacrolimus.
Saffari TM, Bedar M, Zuidam JM, Shin AY, Baan CC, Hesselink DA, Hundepool CA. Saffari TM, et al. Among authors: hesselink da. Expert Rev Clin Pharmacol. 2019 Nov;12(11):1047-1057. doi: 10.1080/17512433.2019.1675507. Epub 2019 Oct 22. Expert Rev Clin Pharmacol. 2019. PMID: 31575290 Review.
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.
Hilbrands L, Budde K, Bellini MI, Diekmann F, Furian L, Grinyó J, Heemann U, Hesselink DA, Loupy A, Oberbauer R, Pengel L, Reinders M, Schneeberger S, Naesens M. Hilbrands L, et al. Among authors: hesselink da. Transpl Int. 2022 May 20;35:10139. doi: 10.3389/ti.2022.10139. eCollection 2022. Transpl Int. 2022. PMID: 35669976 Free PMC article.
One Biomarker to Diagnose Them All?
Hesselink DA, Boer K. Hesselink DA, et al. Transplantation. 2022 Jul 1;106(7):1300-1301. doi: 10.1097/TP.0000000000004142. Epub 2022 Jun 17. Transplantation. 2022. PMID: 35731151 No abstract available.
Iron deficiency after kidney transplantation.
Vinke JSJ, Francke MI, Eisenga MF, Hesselink DA, de Borst MH. Vinke JSJ, et al. Among authors: hesselink da. Nephrol Dial Transplant. 2021 Nov 9;36(11):1976-1985. doi: 10.1093/ndt/gfaa123. Nephrol Dial Transplant. 2021. PMID: 32910168 Free PMC article.
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Bergan S, et al. Among authors: hesselink da. Ther Drug Monit. 2021 Apr 1;43(2):150-200. doi: 10.1097/FTD.0000000000000871. Ther Drug Monit. 2021. PMID: 33711005 Review.
257 results